281 related articles for article (PubMed ID: 32291811)
1. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D
Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811
[TBL] [Abstract][Full Text] [Related]
2. Retail price and availability of illicit cannabis in Canada.
Mahamad S; Hammond D
Addict Behav; 2019 Mar; 90():402-408. PubMed ID: 30530299
[TBL] [Abstract][Full Text] [Related]
3. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis.
Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P
Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645
[TBL] [Abstract][Full Text] [Related]
4. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation.
Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P
Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893
[TBL] [Abstract][Full Text] [Related]
5. Price elasticity of illegal versus legal cannabis: a behavioral economic substitutability analysis.
Amlung M; Reed DD; Morris V; Aston ER; Metrik J; MacKillop J
Addiction; 2019 Jan; 114(1):112-118. PubMed ID: 30194789
[TBL] [Abstract][Full Text] [Related]
6. Legal cannabis market shares during Canada's first year of recreational legalisation.
Armstrong MJ
Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614
[TBL] [Abstract][Full Text] [Related]
7. Availability of legalized cannabis reduces demand for illegal cannabis among Canadian cannabis users: evidence from a behavioural economic substitution paradigm.
Amlung M; MacKillop J
Can J Public Health; 2019 Apr; 110(2):216-221. PubMed ID: 30523535
[TBL] [Abstract][Full Text] [Related]
8. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state.
Smart R; Caulkins JP; Kilmer B; Davenport S; Midgette G
Addiction; 2017 Dec; 112(12):2167-2177. PubMed ID: 28556310
[TBL] [Abstract][Full Text] [Related]
9. Big data on a big new market: Insights from Washington State's legal cannabis market.
Caulkins JP; Bao Y; Davenport S; Fahli I; Guo Y; Kinnard K; Najewicz M; Renaud L; Kilmer B
Int J Drug Policy; 2018 Jul; 57():86-94. PubMed ID: 29709847
[TBL] [Abstract][Full Text] [Related]
10. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.
Wadsworth E; Driezen P; Pacula RL; Hammond D
Drug Alcohol Depend; 2022 Feb; 231():109262. PubMed ID: 34998249
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
[TBL] [Abstract][Full Text] [Related]
12. Reasons for Purchasing Cannabis From Illegal Sources in Legal Markets: Findings Among Cannabis Consumers in Canada and U.S. States, 2019-2020.
Goodman S; Wadsworth E; Hammond D
J Stud Alcohol Drugs; 2022 May; 83(3):392-401. PubMed ID: 35590180
[TBL] [Abstract][Full Text] [Related]
13. Access to cannabis retail stores across Canada 6 months following legalization: a descriptive study.
Myran DT; Brown CRL; Tanuseputro P
CMAJ Open; 2019; 7(3):E454-E461. PubMed ID: 31409593
[TBL] [Abstract][Full Text] [Related]
14. Implications of marijuana purchase task based demand functions for optimal legal pricing of cannabis.
Childs J; Poirier A
Int J Drug Policy; 2021 Sep; 95():103271. PubMed ID: 34049233
[TBL] [Abstract][Full Text] [Related]
15. Mapping cannabis potency in medical and recreational programs in the United States.
Cash MC; Cunnane K; Fan C; Romero-Sandoval EA
PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334
[TBL] [Abstract][Full Text] [Related]
16. Prices and Purchase Sources for Dried Cannabis Flower in the United States, 2019-2020.
Wadsworth E; Driezen P; Pacula RL; Kilmer B; Hammond D
Cannabis Cannabinoid Res; 2023 Oct; 8(5):923-932. PubMed ID: 35363550
[No Abstract] [Full Text] [Related]
17. Illegal drug market responses to state recreational cannabis laws.
Meinhofer A; Rubli A
Addiction; 2021 Dec; 116(12):3433-3443. PubMed ID: 33998087
[TBL] [Abstract][Full Text] [Related]
18. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review.
Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T
Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188
[TBL] [Abstract][Full Text] [Related]
19. Proximity to Legal Cannabis Stores in Canada and Use of Cannabis Sources in the First Three Years of Legalization, 2019-2021.
Wadsworth E; Driezen P; Dilley JA; Gabrys R; Jesseman R; Hammond D
J Stud Alcohol Drugs; 2023 Nov; 84(6):852-862. PubMed ID: 37306374
[TBL] [Abstract][Full Text] [Related]
20. Delta-8 THC Retail Availability, Price, and Minimum Purchase Age.
Rossheim ME; LoParco CR; Walker A; Livingston MD; Trangenstein PJ; Olsson S; McDonald KK; Yockey RA; Luningham JM; Kong AY; Henry D; Walters ST; Thombs DL; Jernigan DH
Cannabis Cannabinoid Res; 2024 Feb; 9(1):363-370. PubMed ID: 36342930
[No Abstract] [Full Text] [Related]
[Next] [New Search]
